BioCentury
ARTICLE | Clinical News

Sarawak began U.S. Phase Ib testing of (+)-calanolide A

October 5, 1998 7:00 AM UTC

Sarawak MediChem Pharmaceuticals Inc., Lemont, Ill. Product: (+)-calanolide A non-nucleoside reverse transcriptase inhibitor (NNRTI) Indication: Treat HIV infection/AIDS Status: Sarawak began U.S. Pha...